Explore
13D/13G Activist Filings
118,856 resultsSome filings may show "N/A" for ticker if the subject is a private fund, SPAC, or unlisted security.
| Filed ↓ | Ticker | Company | Filer | Form | % Owned | Shares |
|---|---|---|---|---|---|---|
| Feb 10, 2026 | R | Ryder System, Inc. | Wellington Management Group LLP | 13G/A | 5.5% | 2.2M |
| Feb 10, 2026 | INSP | Inspire Medical Systems, Inc. | Wellington Management Group LLP | 13G | 7.6% | 2.2M |
| Feb 10, 2026 | SHAK | Shake Shack Inc. | Wellington Management Group LLP | 13G/A | 7.4% | 3.0M |
| Feb 10, 2026 | GNTX | Gentex Corporation | Wellington Management Group LLP | 13G/A | 1.1% | 2.3M |
| Feb 10, 2026 | RUSHA | Rush Enterprises, Inc. | Wellington Management Group LLP | 13G/A | 5.8% | 3.5M |
| Feb 10, 2026 | MCB | Metropolitan Bank Holding Corp. | Wellington Management Group LLP | 13G | 5.8% | 593K |
| Feb 10, 2026 | VIAV | Viavi Solutions Inc. | Wellington Management Group LLP | 13G/A | 4.9% | 11.0M |
| Feb 10, 2026 | SLNO | Soleno Therapeutics, Inc. | Wellington Management Group LLP | 13G | 6.2% | 3.3M |
| Feb 10, 2026 | ODD | Oddity Tech Ltd | BAILLIE GIFFORD & CO | 13G/A | 16.1% | 7.1M |
| Feb 10, 2026 | IOT | Samsara Inc. | BAILLIE GIFFORD & CO | 13G/A | 13.3% | 47.7M |
| Feb 10, 2026 | OCUL | Ocular Therapeutix, Inc | Deep Track Capital, LP | 13G/A | 4.3% | 9.2M |
| Feb 10, 2026 | YALA | Yalla Group Limited | Tao Yang | 13G/A | 42.1% | 67.1M |
| Feb 10, 2026 | CASI | CASI Pharmaceuticals, Inc. | WEI-WU HE, Ph.D. | 13D/A | 45.4% | 14.0M |
| Feb 10, 2026 | N/A | NOBLE ROMANS INC | CORBEL CAPITAL PARTNERS SBIC, L.P. | 13G/A | 9.9% | 5.0M |
| Feb 10, 2026 | BLSH | Bullish | Brendan F. Blumer | 13D/A | 26.8% | 39.2M |
| Feb 10, 2026 | BMBL | Bumble Inc. | Saba Capital Management, L.P. | 13G | 5.3% | 5.9M |
| Feb 10, 2026 | LMNR | Limoneira Company | Global Alpha Capital Management Ltd. | 13G/A | 16.2% | 2.9M |
| Feb 10, 2026 | N/A | SL INVESTMENT FUND II LLC | LOCKHEED MARTIN INVESTMENT MANAGEMENT CO | 13G/A | 0.0% | 0 |
| Feb 10, 2026 | PFSA | Profusa, Inc. | Ascent Partners Fund LLC | 13G/A | 10.0% | 9.6M |
| Feb 10, 2026 | BSLK | Bolt Projects Holdings, Inc. | Ascent Partners Fund LLC | 13G/A | 5.0% | 228K |
| Feb 10, 2026 | AXIA | CENTRAIS ELETRICAS BRASILEIRAS SA ELETROBRAS | GIC Private Limited | 13G/A | 4.4% | 89.1M |
| Feb 10, 2026 | NTIP | NETWORK-1 TECHNOLOGIES, INC. | Clayton Partners LLC | 13G/A | 4.5% | 1.0M |
| Feb 9, 2026 | LUCD | Lucid Diagnostics Inc. | PAVmed Inc. | 13D/A | 27.5% | 38.8M |
| Feb 9, 2026 | GROY | Gold Royalty Corp. | Tether Global Investments Fund, S.I.C.A.F., S.A. | 13D/A | 13.1% | 29.2M |
| Feb 9, 2026 | ANGO | AngioDynamics, Inc. | KEVIN KOTLER | 13G | 5.9% | 2.4M |
| Feb 9, 2026 | PLRX | PLIANT THERAPEUTICS, INC. | Citadel Advisors LLC | 13G | 3.4% | 2.1M |
| Feb 9, 2026 | CORZ | Core Scientific, Inc. | Valiant Capital Management, L.P. | 13G/A | 4.2% | 13.1M |
| Feb 9, 2026 | ANY | Dermata Therapeutics, Inc. | BIGGER CAPITAL FUND L P | 13G/A | 7.9% | 239K |
| Feb 9, 2026 | TIC | TIC Solutions, Inc. | Progeny 3, Inc. | 13G/A | 6.9% | 15.2M |
| Feb 9, 2026 | PAR | PAR Technology Corporation | Progeny 3, Inc. | 13G | 5.1% | 2.1M |
| Feb 9, 2026 | PLYM | Plymouth Industrial REIT, Inc. | Hudson Bay Capital Management LP | 13G/A | 0.7% | 302K |
| Feb 9, 2026 | LEE | Lee Enterprises, Incorporated | Jerrilyn M. Hoffmann Revocable Trust dated May 30, 2001 | 13D/A | 51.8% | 11.5M |
| Feb 9, 2026 | CPIX | Cumberland Pharmaceuticals Inc. | A.J. Kazimi | 13G | 38.4% | 5.8M |
| Feb 9, 2026 | ETHZ | ETHZilla Corp | Hudson Bay Capital Management LP | 13G/A | 1.8% | 350K |
| Feb 9, 2026 | ATXS | Astria Therapeutics, Inc. | Perceptive Advisors LLC | 13D/A | 0.0% | 0 |
| Feb 9, 2026 | ALXO | ALX Oncology Holdings Inc. | RA Capital Management, L.P. | 13G | 9.9% | 13.1M |
| Feb 9, 2026 | N/A | BRERA HOLDINGS PLC | RBCH Ltd. | 13D/A | 22.3% | 22.2M |
| Feb 9, 2026 | SSNC | SS&C Technologies Holdings, Inc. | William C. Stone | 13G/A | 14.3% | 35.2M |
| Feb 9, 2026 | RAPT | RAPT Therapeutics, Inc. | Glazer Capital, LLC | 13G | 5.4% | 1.5M |
| Feb 9, 2026 | LIVN | LivaNova PLC | Integrated Core Strategies (US) LLC | 13G/A | 5.6% | 3.1M |
| Feb 9, 2026 | OS | OneStream, Inc. | Glazer Capital, LLC | 13G | 6.8% | 6.2M |
| Feb 9, 2026 | BETR | Better Home & Finance Holding Co | Orange Capital Ventures LP | 13G/A | 5.8% | 587K |
| Feb 9, 2026 | CATX | Perspective Therapeutics, Inc. | Commodore Capital LP | 13G | 9.9% | 11.9M |
| Feb 9, 2026 | FLNC | Fluence Energy, Inc. | SPT Invest Management Sarl | 13G/A | 0.0% | 0 |
| Feb 9, 2026 | DORM | Dorman Products, Inc. | Marc H. Berman | 13G/A | 5.1% | 1.5M |
| Feb 9, 2026 | ASPI | ASP Isotopes Inc. | BNP Paribas Asset Management UK Ltd | 13G/A | 0.9% | 944K |
| Feb 9, 2026 | RDAC | RISING DRAGON ACQUISITION CORP | THE GOLDMAN SACHS GROUP, INC. | 13G/A | 1.9% | 142K |
| Feb 9, 2026 | N/A | Muzero Acquisition Corp | Muzero Acquisition Sponsors LLC | 13D | 25.8% | 7.0M |
| Feb 9, 2026 | MAMO | Massimo Group | Asia International Securities Exchange Co., Ltd. | 13G | 1.0% | 400K |
| Feb 9, 2026 | OUT | OUTFRONT MEDIA INC. | THE GOLDMAN SACHS GROUP, INC. | 13G/A | 0.0% | 0 |